MedPath

Delivery Room CPAP in Extremely Low Birth Weight Infants

Phase 1
Completed
Conditions
Infant, Low Birth Weight
Continuous Positive Airway Pressure
Infant, Small for Gestational Age
Infant, Premature
Bronchopulmonary Dysplasia
Infant, Newborn
Interventions
Device: CPAP/PEEP
Device: Standard management practices
Registration Number
NCT01223274
Lead Sponsor
NICHD Neonatal Research Network
Brief Summary

This pilot study was designed to determine the feasibility of randomizing extremely low birth weight (ELBW) infants \<28 weeks' gestation who required resuscitation to one of two resuscitation methods, either: (a) 100% oxygen by facemask and continuous positive airway pressure (CPAP) or positive pressure ventilation (PPV) with positive end-expiratory pressure (PEEP), if the infant required PPV (the intervention group); or (b) 100% oxygen and no CPAP and no PEEP if the infant required PPV (the control group).

Detailed Description

Previous studies suggested that early continuous airway positive pressure (CPAP) may be beneficial in reducing ventilator dependence and subsequent bronchopulmonary dysplasia (BPD) in extremely low birth weight (ELBW) infants. These studies did not test for the optimal timing of CPAP initiation or compare CPAP/PEEP initiation in the delivery room against standard resuscitation methods. Current practice at the time was for the ELBW infant to be intubated early and administered prophylactic surfactant. The feasibility of initiating CPAP in the DR and continuing this therapy without intubation for surfactant had not been determined prospectively in a population of ELBW infants.

This pilot study was designed to determine the feasibility of randomizing extremely low birth weight (ELBW) infants \<28 weeks' gestation who required resuscitation to one of two resuscitation methods, either: (a) 100% oxygen by facemask and continuous positive airway pressure (CPAP) or positive pressure ventilation (PPV) with positive end-expiratory pressure (PEEP), if the infant required PPV (the intervention group); or (b) 100% oxygen and no CPAP and no PEEP if the infant required PPV (the control group).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
104
Inclusion Criteria
  • Infants delivered in a specially equipped resuscitation room(s)
  • <28 weeks gestational age by best obstetric estimate before delivery
  • Requiring resuscitation
Exclusion Criteria
  • No known major congenital anomalies
  • Decision made not to provide full resuscitation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CPAP/PEEP InterventionCPAP/PEEPInfants received 100% oxygen by facemask and continuous positive airway pressure (CPAP) or positive pressure ventilation (PPV) with positive end-expiratory pressure (PEEP), if the infant required PPV.
ControlStandard management practicesControl infants were treated with 100% oxygen and no CPAP. When a control infant required PPV, no PEEP was used.
Primary Outcome Measures
NameTimeMethod
Compliance with the study protocol6 months
Secondary Outcome Measures
NameTimeMethod
Extent of resuscitation neededUntil admission to NICU
Bronchopulmonary dysplasia (BPD)36 weeks of life
Number and duration of intubation attemptsUntil admission to the NICU
Infants who required positive pressure ventilation for resuscitation in the DR/resuscitation roomUntil admission to the NICU
Five minute Apgar5 minutes after birth
Total duration of mechanical ventilationUntil hospital discharge or 120 days of life
Proportion of infants requiring surfactant1 day of life

Trial Locations

Locations (6)

University of California at San Diego

🇺🇸

San Diego, California, United States

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

RTI International

🇺🇸

Durham, North Carolina, United States

Cincinnati Children's Medical Center

🇺🇸

Cincinnati, Ohio, United States

Case Western Reserve University, Rainbow Babies and Children's Hospital

🇺🇸

Cleveland, Ohio, United States

University of Miami

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath